U.S. Entertainment Stock News

NasdaqGS:MOMO
NasdaqGS:MOMOInteractive Media and Services

Hello Group’s Softer Q3 Results and Outlook Could Be A Game Changer For Hello Group (MOMO)

In the past quarter, Hello Group Inc. reported third-quarter 2025 revenue of CNY 2,650.12 million and net income of CNY 348.89 million, both slightly lower than a year earlier, with earnings per share also declining on a basic and diluted basis. For the nine months to September 30 2025, the company’s weaker revenue and net income, combined with fourth-quarter guidance for a further year-over-year revenue decline, highlight continued pressure on its core social and entertainment...
NYSE:OWLT
NYSE:OWLTMedical Equipment

Owlet (OWLT): Valuation Check After New 1 Natural Way Partnership Expands BabySat Insurance Access

Owlet (OWLT) is back on traders’ screens after announcing a new DME partnership with 1 Natural Way, opening insurance backed access to its FDA cleared BabySat monitor for higher risk infants nationwide. See our latest analysis for Owlet. The DME deal lands after a busy stretch that included the UK and Ireland rollout of Owlet360 and a recent shelf registration closing. The market seems to be reassessing the story, with the share price at $14.05 and a powerful year to date share price return...
NasdaqCM:MDXG
NasdaqCM:MDXGBiotechs

MiMedx (MDXG): Fresh Clinical Evidence Spurs a Closer Look at the Stock’s Valuation and Long-Term Upside Potential

MiMedx Group (MDXG) just added fresh peer reviewed backing for its placental allograft products, with a new Journal of Inflammation study underscoring their immunomodulatory role in complex wound healing and longer term competitive positioning. See our latest analysis for MiMedx Group. Even with this new clinical validation, MiMedx Group’s $7.05 share price sits well below its highs, with a year-to-date share price return of negative 24.03 percent and a powerful three-year total shareholder...